Security | KVYO / Klaviyo, Inc. |
Insider | Ed Hallen |
Insider Purchases - Short Term Profit Analysis
In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Ed Hallen in KVYO / Klaviyo, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Max |
Price at Max |
Max Profit ($) |
Max Return (%) |
---|---|---|---|---|---|---|---|
There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Sales - Short Term Loss Analysis
In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Ed Hallen in KVYO / Klaviyo, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Min |
Price at Min |
Max Loss Avoided ($) |
Max Loss Avoided (%) |
---|---|---|---|---|---|---|---|
There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Transaction History
File Date |
Trade Date |
Form | Insider | Ticker | Security Title | Code | Direct | Exercise Price |
Unit Price |
Units Changed |
Value Changed (1K) |
Remaining Options |
Remaining Shares |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-09-17 | 2025-09-15 | 4 | Hallen Ed By Hodgkins LLC | KVYO | Series A Common Stock | I | -20,260 | 702,216 | ||||||
2025-09-17 | 2025-09-15 | 4 | Hallen Ed By Hodgkins LLC | KVYO | Series A Common Stock | I | 31.7300 | -67,524 | -2,143 | 722,476 | ||||
2025-09-17 | 2025-09-15 | 4 | Hallen Ed By Hodgkins Trust | KVYO | Series A Common Stock | I | 31.6500 | -22,224 | -703 | 177,776 | ||||
2025-09-12 | 2025-09-11 | 4 | Hallen Ed By Hodgkins LLC | KVYO | Series A Common Stock | I | 790,000 | 790,000 | ||||||
2025-09-12 | 2025-09-11 | 4 | Hallen Ed By Hodgkins Trust | KVYO | Series A Common Stock | I | 200,000 | 200,000 | ||||||
2025-09-12 | 2025-09-11 | 4 | Hallen Ed | KVYO | Series A Common Stock | D | -990,000 | 0 | ||||||
2025-09-12 | 2025-09-11 | 4 | Hallen Ed | KVYO | Series A Common Stock | D | 990,000 | 990,000 |